RZLT Stock Analysis: Buy, Sell, or Hold?
RZLT - Rezolute, Inc. Common Stock (NV)
$3.21
0.12 (3.72%)
▲
5d:
-2.88%
30d:
-12.19%
90d:
+2.72%
BUY
HIGH Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 12, 2026
3d
Smart Money Accumulation
RZLT is down 3.4% this week, but smart money is accumulating calls. Top strike: $2.5 2026-07-17 with 441 OI. Call ratio: 100% View Scanner →
Strength: 6.7/10
Get Alerted When RZLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RZLT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: RZLT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: RZLT is currently trading at $3.21, which is considered slightly low relative to its 30-day fair value range of $3.10 to $3.51.
Technical Outlook: Technically, RZLT is in a strong uptrend. Immediate support is located at $2.99, while resistance sits at $3.54. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.12 (+65.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RZLT is in a strong uptrend. Immediate support is located at $2.99, while resistance sits at $3.54. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.12 (+65.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.10 -
$3.51
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 65.9% below Wall St target ($5.12)
Trading Range Analysis
30-Day Trading Range
$3.10 -
$3.51
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.99
Resistance Level
$3.54
Current Trend
Strong Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.52
Wall Street Target
$5.13
(+65.9%)
Share & Embed Analysis
Last updated: May 08, 2026 10:19 AM ET
Data refreshes hourly during market hours. Next update: 11:18 AM
Data refreshes hourly during market hours. Next update: 11:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RZLT showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Daron Evans
BUY
40000 shares
2025-12-15
Daron Evans
BUY
5000 shares
2025-12-15
Nevan C Elam
BUY
32000 shares
2025-12-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 61 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 49 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 55 HOLD |
Advanced RZLT Option Strategies
Professional options setups generated by AI based on today's RZLT price and gamma walls.
